Vimal Mehta - CEO and President, Director at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Stock Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Vimal Mehta - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 480K $687K $1.43 Jul 22, 2025 By BioXcel LLC
Common Stock 20.1K $28.8K $1.43 Jul 22, 2025 Direct
Restricted Stock Units 1.97K $848 $0.35 Sep 15, 2025 Direct Common Stock
Common Stock 125 $178 $1.43 Jul 22, 2025 By Spouse
Stock Option (right to buy) 660K Jan 7, 2025 Direct Common Stock

Transactions reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.